N
CuraGen expects to publish the collaboration’s results and to begin releasing data to the public later this year. The Berkeley group will provide gene clones that CuraGen will process with its PathCalling technology to identify protein interactions within Drosophila’s biological pathways. Once the interactions have been pinpointed, scientists from both organizations will cooperate to annotate the resulting data into a resource for human disease research.